Safety and effectiveness of dipeptidyl peptidase-4 inhibitors versus intermediate-acting insulin or placebo for patients with type 2 diabetes failing two oral antihyperglycaemic agents: a systematic review and network meta-analysis

Safety and effectiveness of dipeptidyl peptidase-4 inhibitors versus intermediate-acting insulin or placebo for patients with type 2 diabetes failing two oral antihyperglycaemic agents: a systematic review and network meta-analysis

Bibliographic Details
Main Authors: Tricco, Andrea C, Antony, Jesmin, Khan, Paul A, Ghassemi, Marco, Hamid, Jemila S, Ashoor, Huda, Blondal, Erik, Soobiah, Charlene, Yu, Catherine H, Hutton, Brian, Hemmelgarn, Brenda R, Moher, David, Majumdar, Sumit R, Straus, Sharon E
Format: Online
Language:English
Published: BMJ Publishing Group 2014
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4275675/

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4275675/

Similar Items